These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21791011)

  • 21. A fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates.
    Hammarström P; Simon R; Nyström S; Konradsson P; Aslund A; Nilsson KP
    Biochemistry; 2010 Aug; 49(32):6838-45. PubMed ID: 20604540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thioflavine-T and Congo Red reveal the polymorphism of insulin amyloid fibrils when probed by polarization-resolved fluorescence microscopy.
    Duboisset J; Ferrand P; He W; Wang X; Rigneault H; Brasselet S
    J Phys Chem B; 2013 Jan; 117(3):784-8. PubMed ID: 23289901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors.
    Levy-Sakin M; Shreberk M; Daniel Y; Gazit E
    Islets; 2009; 1(3):210-5. PubMed ID: 21099274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field.
    Skaat H; Sorci M; Belfort G; Margel S
    J Biomed Mater Res A; 2009 Nov; 91(2):342-51. PubMed ID: 18980178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation.
    Skaat H; Belfort G; Margel S
    Nanotechnology; 2009 Jun; 20(22):225106. PubMed ID: 19433878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary nucleation and accessible surface in insulin amyloid fibril formation.
    Foderà V; Librizzi F; Groenning M; van de Weert M; Leone M
    J Phys Chem B; 2008 Mar; 112(12):3853-8. PubMed ID: 18311965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncooperative dimethyl sulfoxide-induced dissection of insulin fibrils: toward soluble building blocks of amyloid.
    Loksztejn A; Dzwolak W
    Biochemistry; 2009 Jun; 48(22):4846-51. PubMed ID: 19385641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gold nanoparticles as amyloid-like fibrillogenesis inhibitors.
    Hsieh S; Chang CW; Chou HH
    Colloids Surf B Biointerfaces; 2013 Dec; 112():525-9. PubMed ID: 24060166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apigenin reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids.
    Amini R; Yazdanparast R; Bahramikia S
    Int J Biol Macromol; 2013 Sep; 60():334-40. PubMed ID: 23777711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vortex-induced formation of insulin amyloid superstructures probed by time-lapse atomic force microscopy and circular dichroism spectroscopy.
    Loksztejn A; Dzwolak W
    J Mol Biol; 2010 Jan; 395(3):643-55. PubMed ID: 19891974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH.
    Yamamoto K; Yagi H; Ozawa D; Sasahara K; Naiki H; Goto Y
    J Mol Biol; 2008 Feb; 376(1):258-68. PubMed ID: 18155723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways.
    Grudzielanek S; Velkova A; Shukla A; Smirnovas V; Tatarek-Nossol M; Rehage H; Kapurniotu A; Winter R
    J Mol Biol; 2007 Jul; 370(2):372-84. PubMed ID: 17521669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways.
    Morozova-Roche LA; Zamotin V; Malisauskas M; Ohman A; Chertkova R; Lavrikova MA; Kostanyan IA; Dolgikh DA; Kirpichnikov MP
    Biochemistry; 2004 Aug; 43(30):9610-9. PubMed ID: 15274615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic inhibition of amyloidogenic proteins by two naphthoquinone-tryptophan hybrid molecules.
    Scherzer-Attali R; Shaltiel-Karyo R; Adalist YH; Segal D; Gazit E
    Proteins; 2012 Aug; 80(8):1962-73. PubMed ID: 22488522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembly of tissue transglutaminase into amyloid-like fibrils using physiological concentration of Ca2+.
    Kalhor HR; Shahin V F; Fouani MH; Hosseinkhani H
    Langmuir; 2011 Sep; 27(17):10776-84. PubMed ID: 21790128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
    Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
    J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of multiple amyloidogenic sequences in laminin-1.
    Kasai S; Urushibata S; Hozumi K; Yokoyama F; Ichikawa N; Kadoya Y; Nishi N; Watanabe N; Yamada Y; Nomizu M
    Biochemistry; 2007 Apr; 46(13):3966-74. PubMed ID: 17348688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.